Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > Tata Mutual Fund > Tata India Pharma & HealthCare Fund - Direct Plan (G)

Tata India Pharma & HealthCare Fund - Direct Plan (G)

PLAN: Direct OPTIONS: Growth
9.348 0.08 (0.84%)

NAV as on 19 Jan, 2018

CRISIL MF RANK

Not Ranked

Riskometer

MODERATELY HIGH

MODERATELY HIGH

  • Principal at moderately high risk.
FUND FAMILY : Tata Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL (for quarter ended Sep 2017) since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on 19 Jan, 2018)

Period Returns (%) Rank #
1 mth 4.1 1
3 mth 6.1 5
6 mth 1.1 7
1 year 5.5 4
2 year -1.8 7
3 year - -
5 year - -

# Moneycontrol Rank within 8 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2017 6.3 -5.4 -6.1 9.2 5.8
2016 -6.2 - 1.3 -10.7 -13.2
2015 - - - - -

View where it stands within its peers

* Returns over 1 year are Annualised

* Calculation Remark - Dividends are reinvested at the rate of return

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns 4.1 6.1 1.1 5.5 -1.8 -- --
Category avg 3.1 5.7 3.6 3.2 -0.2 2.3 11.8
Difference of Fund returns and Category returns 1.0 0.4 -2.5 2.3 -1.6 -- --
Best of category 4.1 9.0 6.8 9.8 3.3 5.0 18.4
Worst of category 1.9 4.2 0.2 1.2 -3.5 1.8 14.2
Benchmark returns # 3.6 0.5 -5.8 -7.2 -7.3 -5.0 10.2
Difference of Fund returns and Benchmark returns 0.5 5.6 6.9 12.7 5.5 -- --
# Benchmark Index: NIFTY PHARMA

Investment Info

Investment Objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the Pharma & Healthcare sectors in India.

Scheme details

Fund Type Open-Ended
Investment Plan Dividend
Launch date Dec 18, 2015
Benchmark NIFTY PHARMA
Asset Size (Rs cr) 16.11 (Dec-31-2017)
Minimum Investment Rs.5000
Last Dividend N.A. View Dividend History
Bonus N.A.
Fund Manager Sonam Udasi / Rupesh Patel
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 0.00%
Load Comments N.A.

Contact Details

Regd. Office Mulla House, 4th Floor, 51 M.G. Road, Flora Fountain, Mumbai , 400001
Tel. No. 022 66315191/92/93
Fax No. 022 66315194
Email service@tataamc.com
Website http://www.tatamutualfund.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
1,536.22 8.7 6.3 8.8 4.1 16.2
SBI Pharma Fund (G) Not Ranked
860.04 4.2 1.0 -- 2.9 17.3
UTI Pharma & Health (G) Not Ranked
329.03 6.9 3.5 4.4 1.8 14.2
Reliance Pharma Fund - Direct (G) Not Ranked
215.62 9.0 6.8 9.8 5.0 17.2
SBI Pharma Fund - Direct (G) Not Ranked
214.61 4.6 1.7 1.2 4.2 18.4
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Dec 29, 17)

Equity Sector Value
(Rs cr)
Asset %
Sun Pharma Pharmaceuticals 3.70 22.95
Divis Labs Pharmaceuticals 1.56 9.68
Piramal Enter Pharmaceuticals 1.30 8.06
Syngene Intl Miscellaneous 1.10 6.82
Aurobindo Pharm Pharmaceuticals 1.08 6.71
Ipca Labs Pharmaceuticals 0.98 6.11
Cadila Health Pharmaceuticals 0.84 5.20
Apollo Hospital Services 0.73 4.51
Dishman Carboge Miscellaneous 0.71 4.42
Alembic Pharma Pharmaceuticals 0.66 4.08

Full Portfolio

Sector Allocation (Dec 29, 17)

Sector %

1-Year

HighLow

Pharmaceuticals 78.52 87.23 87.23
Miscellaneous 11.24 2.69 2.69
Services 9.20 7.73 7.73

View All Sectors

Asset Allocation (%)(Dec 29, 17)

Equity 98.96
Others 0.00
Debt 0.00
Mutual Funds N.A
Money Market 0.00
Cash / Call 1.04

View All

Concentration

Holdings (%)
Top 5 54.22
Top 10 78.54
Sector (%)
Top 3 98.96

News & Videos

News

Messages & Community

Sections
Follow us on
Available On